enhance 发表于 2025-3-25 03:36:45

Submitted on: 21 February 2014.
Revised on: 10 March 2014.
Accepted on: 20 March 2014.
Review of Corporate Finance Studies

修剪过的树篱 发表于 2025-3-25 08:03:15

http://reply.papertrans.cn/3/266/26541/26541-22.png

miniature 发表于 2025-3-25 12:11:06

http://reply.papertrans.cn/3/266/26541/26541-23.png

Hippocampus 发表于 2025-3-25 16:49:20

http://reply.papertrans.cn/3/266/26541/26541-24.png

EXULT 发表于 2025-3-25 23:32:51

Submitted on: 01 January 2009.
Revised on: 09 February 2009.
Accepted on: 24 February 2009.
Review of Corporate Finance Studies

注射器 发表于 2025-3-26 00:39:11

http://reply.papertrans.cn/3/266/26541/26541-26.png

FELON 发表于 2025-3-26 06:22:49

http://reply.papertrans.cn/3/266/26541/26541-27.png

宪法没有 发表于 2025-3-26 11:33:59

http://reply.papertrans.cn/3/266/26541/26541-28.png

功多汁水 发表于 2025-3-26 15:26:16

http://reply.papertrans.cn/3/266/26541/26541-29.png

努力赶上 发表于 2025-3-26 20:10:38

http://reply.papertrans.cn/3/266/26541/26541-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊Review of Corporate Finance Studies 2024/2025影响因子:1.908 (REV CORP FINANC STUD) (2046-9128). (BUSINESS, FINANCE)(商